Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Icon ( (ICLR) ) has issued an announcement.
ICON plc has announced its upcoming Annual General Meeting (AGM) scheduled for July 22, 2025, at its headquarters in Dublin, Ireland. The AGM will address several resolutions, including the re-election of all current board members, the review of 2024 financial accounts audited by KPMG, and the appointment of Ernst & Young as the new auditors for 2025. Additionally, the meeting will cover resolutions on share issuance, buy-back authorizations, and treasury share reissuance, reflecting the company’s strategic financial maneuvers to align with Nasdaq rules and provide shareholder protections. These resolutions, requiring varying levels of shareholder approval, underscore ICON’s commitment to maintaining robust governance and shareholder engagement.
The most recent analyst rating on (ICLR) stock is a Buy with a $380.00 price target. To see the full list of analyst forecasts on Icon stock, see the ICLR Stock Forecast page.
Spark’s Take on ICLR Stock
According to Spark, TipRanks’ AI Analyst, ICLR is a Neutral.
Icon’s overall score reflects a mix of strong financial performance and efficient cash flow management, weighed down by technical indicators showing a bearish trend and a cautious outlook from the earnings call. The valuation is moderate, but the lack of dividend yield limits appeal for certain investors. The company’s focus on innovation and partnerships provides a potential for mid-to-long-term growth, but current market challenges and revenue declines pose significant risks.
To see Spark’s full report on ICLR stock, click here.
More about Icon
ICON plc is a global provider in the healthcare and pharmaceutical industry, primarily offering clinical research services. The company focuses on delivering outsourced development and commercialization services to pharmaceutical, biotechnology, and medical device industries, positioning itself as a key player in the clinical research organization sector.
Average Trading Volume: 1,482,239
Technical Sentiment Signal: Sell
Current Market Cap: $11.69B
Learn more about ICLR stock on TipRanks’ Stock Analysis page.